Intelligence / Healthtech / New Clinical Trials / Ahn-Gook Pharmaceuticals Co.,Ltd
Clinicaltrial registered30 Oct 2026
Ahn-Gook Pharmaceuticals Co.,Ltd
30 Oct 2026: Trial registered · A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 30 Oct 2026
- Title
- A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy
- Conditions
- Hypertension (HTN), Hypertension, Essential (Primary) Hypertension
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Reference
- NCT07907822
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Ahn-Gook Pharmaceuticals Co.,Ltd
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.